Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled Trial.
Sarkis ManoukianHelen MasonSuzanne HagenRohna KearneyKirsteen GoodmanCatherine BestAndrew EldersLynn MeloneLucy DwyerMelanie DembinskyAethele KhundaKaren Lesley GuerreroDoreen McClurgJohn NorrieRanee ThakarCarol BuggePublished in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2024)
Results suggest that pessary SM is likely to be cost-effective. The decision analytic model suggests that this result is likely to persist over longer durations.